310 related articles for article (PubMed ID: 17950827)
21. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
22. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
Garg P; Mauri L
Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
[TBL] [Abstract][Full Text] [Related]
24. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R
Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255
[TBL] [Abstract][Full Text] [Related]
25. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.
Pinto Slottow TL; Steinberg DH; Roy PK; Buch AN; Okabe T; Xue Z; Kaneshige K; Torguson R; Lindsay J; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Am J Cardiol; 2008 Aug; 102(3):298-303. PubMed ID: 18638590
[TBL] [Abstract][Full Text] [Related]
26. Very late thrombosis after drug-eluting stents.
Feres F; Costa JR; Abizaid A
Catheter Cardiovasc Interv; 2006 Jul; 68(1):83-8. PubMed ID: 16763989
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations.
Paradis JM; Ducrocq G; Tanguay JF
Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176
[TBL] [Abstract][Full Text] [Related]
29. Pathology of drug-eluting stents: implications for coronary intervention.
Finn AV; Nakazawa G; Virmani R
Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436
[TBL] [Abstract][Full Text] [Related]
30. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
31. Very late thrombosis of drug-eluting stents: a brief literature review and case example.
Agarwal SK; Shawl F; Raman VK; Binbrek AS
J Invasive Cardiol; 2008 Dec; 20(12):655-8. PubMed ID: 19057030
[TBL] [Abstract][Full Text] [Related]
32. Unrestricted use of drug-eluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.
Abbott JD; Voss MR; Nakamura M; Cohen HA; Selzer F; Kip KE; Vlachos HA; Wilensky RL; Williams DO
J Am Coll Cardiol; 2007 Nov; 50(21):2029-36. PubMed ID: 18021868
[TBL] [Abstract][Full Text] [Related]
33. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Newsome LT; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
[TBL] [Abstract][Full Text] [Related]
34. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
Sacha J; Wester A; Pluta W
Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
[TBL] [Abstract][Full Text] [Related]
35. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
[TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
[TBL] [Abstract][Full Text] [Related]
38. Late coronary stent thrombosis.
Thuesen L; Holm NR
Minerva Med; 2010 Feb; 101(1):25-33. PubMed ID: 20228718
[TBL] [Abstract][Full Text] [Related]
39. Recurrent very late drug-eluting stent thrombosis.
Pesarini G; Arieti M; Spadaro R; Vassanelli C; Ribichini F
Cardiovasc Revasc Med; 2009; 10(2):130-5. PubMed ID: 19327678
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
